NCT03816345 2026-04-13Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONational Cancer Institute (NCI)Phase 1 Recruiting300 enrolled
NCT03656627 2023-02-15Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseAlliance Foundation Trials, LLC.Phase 1 Terminated7 enrolled